Free Biologics Are Real: How Patient Assistance Programs Are Making $50,000-a-Year Drugs Accessible
For patients prescribed biologic medications—some of which carry annual price tags exceeding $50,000—the sticker price can feel like a death sentence for their finances. Yet a growing ecosystem of manufacturer-sponsored patient assistance programs is quietly providing these same drugs at little to no cost for qualifying Americans. This investigative overview explains how these programs work, who qualifies, and how to apply.